Key Insights
- Significantly high institutional ownership implies Bristol-Myers Squibb’s stock price is sensitive to their trading actions
- The top 25 shareholders own 49% of the company
- Insiders have been buying lately
If you want to know who really controls Bristol-Myers Squibb Company (NYSE:BMY), then you’ll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions with 77% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
Last week’s 6.0% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. The one-year return on investment is currently 26% and last week’s gain would have been more than welcomed.
Let’s take a closer look to see what the different types of shareholders can tell us about…
